Two recent studies (N = 170 and N = 65 respectively) observed that S100A16 is significantly upregulated in lung adenocarcinoma (LUAD) and might be an independent prognostic indicator of poor OS [7, 8]. Here, S100A16 is linked to lung adenocarcinoma.